Response to the letter to the editor regarding "safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke patients with direct oral anticoagulation". [PDF]
Mers L, Gerner ST.
europepmc +1 more source
Targeted Thrombolysis via CCR2-Engineered Macrophage-Mimicking Microbubbles Safely Ablates Venous, Arterial, and Microvascular Thrombosis. [PDF]
Li B +8 more
europepmc +1 more source
Thrombolytic agents, more options, more challenges. [PDF]
Dong Y +9 more
europepmc +1 more source
Effect of the Coronavirus Disease 2019 Pandemic on Retinal Artery Occlusion. [PDF]
Muto T +3 more
europepmc +1 more source
Neuronavigation-assisted stereotactic minimally invasive puncture with tenecteplase for the treatment of acute spontaneous deep intracerebral haemorrhage (NAS-TNK): rationale and design of a multicentre randomised trial. [PDF]
Wang M +8 more
europepmc +1 more source
Intravenous thrombolysis for acute ischemic stroke in the extended time window of 4.5-24 h: a systematic review and network meta-analysis of randomized controlled trials. [PDF]
Yu X, Sun X, Yang F.
europepmc +1 more source
Magnetic/photothermal dual-driven micro/nanorobots for synergistic NO-mediated photothermal thrombolysis. [PDF]
Kang W +8 more
europepmc +1 more source
Toward improved thrombolysis in ischemic stroke: targeting nonfibrin components. [PDF]
De Meyer SF.
europepmc +1 more source
Angioedema as anaphylactic reaction following tenecteplase administration in acute ischemic stroke: A case report. [PDF]
Čepin U +5 more
europepmc +1 more source
Efficacy and safety of tenecteplase versus urokinase in the treatment of acute ischemic stroke. [PDF]
Li D, Huang S, Wang X, Hong Z, Qiu X.
europepmc +1 more source

